| Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins FC Church, HE Swaisgood, DH Porter, GL Catignani Journal of dairy science 66 (6), 1219-1227, 1983 | 1831 | 1983 |
| The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature JCW Silverman G.A., P.I. Bird, R.W. Carrell, F.C. Church, P.B. Coughlin, P.G ... J. Biol. Chem. 276, 33293-33296, 2001 | 1582 | 2001 |
| Serpins in thrombosis, hemostasis and fibrinolysis JC Rau, LM Beaulieu, JA Huntington, FC CHURCH Journal of thrombosis and haemostasis 5, 102-115, 2007 | 455 | 2007 |
| A randomized cross-over study on the effects of levonorgestrel-and desogestrel-containing oral contraceptives on the anticoagulant pathways G Tans, J Curvers, S Middeldorp, MCLGD Thomassen, JCM Meijers, ... Thrombosis and haemostasis 84 (07), 15-21, 2000 | 282 | 2000 |
| Antithrombin activity of fucoidan: the interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin FC Church, JB Meade, RE Treanor, HC Whinna Journal of Biological Chemistry 264 (6), 3618-3623, 1989 | 260 | 1989 |
| Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism TP Baglin, RW Carrell, FC Church, CT Esmon, JA Huntington Proceedings of the National Academy of Sciences 99 (17), 11079-11084, 2002 | 255 | 2002 |
| Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex (∗) AR Rezaie, ST Cooper, FC Church, CT Esmon Journal of Biological Chemistry 270 (43), 25336-25339, 1995 | 240 | 1995 |
| Protein Z-dependent regulation of coagulation GJ Broze Jr Thrombosis and haemostasis 86 (07), 08-13, 2001 | 238 | 2001 |
| Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice KR Machlus, JC Cardenas, FC Church, AS Wolberg Blood, The Journal of the American Society of Hematology 117 (18), 4953-4963, 2011 | 237 | 2011 |
| Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and α1-antitrypsin-trypsin complexes is mediated by the low density … MZ Kounnas, FC Church, WS Argraves, DK Strickland Journal of Biological Chemistry 271 (11), 6523-6529, 1996 | 231 | 1996 |
| An o-phthalaldehyde spectrophotometric assay for proteinases FC Church, DH Porter, GL Catignani, HE Swaisgood Analytical biochemistry 146 (2), 343-348, 1985 | 230 | 1985 |
| Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer JG Wang, JE Geddings, MM Aleman, JC Cardenas, ... Blood, The Journal of the American Society of Hematology 119 (23), 5543-5552, 2012 | 228 | 2012 |
| Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. MJ Griffith, CM Noyes, FC Church Journal of Biological Chemistry 260 (4), 2218-2225, 1985 | 195 | 1985 |
| Endothelial protein C receptor CT Esmon, J Xu, J Gu, D Qu, Z Laszik, G Ferrell, DJ Stearns-Kurosawa, ... Thrombosis and haemostasis 82 (08), 251-258, 1999 | 183 | 1999 |
| Control of the coagulation system by serpins: getting by with a little help from glycosaminoglycans RN Pike, AM Buckle, BF le Bonniec, FC Church The FEBS journal 272 (19), 4842-4851, 2005 | 176 | 2005 |
| Interaction of heparin cofactor II with biglycan and decorin. HC Whinna, HU Choi, LC Rosenberg, FC Church Journal of Biological Chemistry 268 (6), 3920-3924, 1993 | 146 | 1993 |
| Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin CA Holland, AT Henry, HC Whinna, FC Church FEBS letters 484 (2), 87-91, 2000 | 144 | 2000 |
| Heparin binding to protein C inhibitor. CW Pratt, FC Church Journal of Biological Chemistry 267 (13), 8789-8794, 1992 | 144 | 1992 |
| Characterization of the glycosaminoglycan-binding region of lactoferrin HF Wu, DM Monroe, FC Church Archives of biochemistry and biophysics 317 (1), 85-92, 1995 | 130 | 1995 |
| Treatment options for motor and non-motor symptoms of Parkinson’s disease FC Church Biomolecules 11 (4), 612, 2021 | 128 | 2021 |
Maureane HoffmanProfessor of Pathology, Duke UniversityAdresse e-mail validée de med.unc.edu
